Literature DB >> 14766830

Genetic diversity of cell-invasive erythromycin-resistant and -susceptible group A streptococci determined by analysis of the RD2 region of the prtF1 gene.

Cinzia Spinaci1, Gloria Magi, Claudia Zampaloni, Luca A Vitali, Claudia Paoletti, Maria R Catania, Manuela Prenna, Luigi Ferrante, Sandro Ripa, Pietro E Varaldo, Bruna Facinelli.   

Abstract

The RD2 region of the internalization-associated gene prtF1, which encodes the fibronectin-binding repeat domain type 2 of protein F1, plays a crucial role in the entry of group A streptococci (GAS) into epithelial cells. A molecular study of the variability of the RD2 region was carried out with 77 independent Italian GAS, 66 erythromycin resistant (ER) and 11 erythromycin susceptible (ES), which had previously been investigated for the association between erythromycin resistance and ability to enter human respiratory cells. The amplicons obtained from PCR analysis of the RD2 region were consistent with a number of RD2 repeats ranging from one to five, more frequently four (n = 30), three (n = 27), and one (n = 18). A new method to type cell-invasive GAS (RD2 typing) was developed by combining PCR analysis of the RD2 region and restriction analysis of PCR products with endonucleases HaeIII, DdeI, and HinfI. Overall, 10 RD2 types (a to j) were distinguished (all detected among the 66 ER isolates, four detected among the 11 ES isolates). Comparison and correlation of RD2 typing data with the genotype and phenotype of macrolide resistance and with data from PCR M typing and SmaI macrorestriction analysis allowed us to identify 41 different clones (31 among the 66 ER isolates and 10 among the 11 ES isolates). Three major clones accounted for 40% of the isolates (47% of ER strains). Some ES isolates appeared to be related to ER isolates with identical combinations of RD2 type and emm type. While simultaneous use of different typing methods is essential for a thorough investigation of GAS epidemiology, RD2 typing may be especially helpful in typing cell-invasive GAS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766830      PMCID: PMC344491          DOI: 10.1128/JCM.42.2.639-644.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Co-operative binding of human fibronectin to Sfbl protein triggers streptococcal invasion into respiratory epithelial cells.

Authors:  S R Talay; A Zock; M Rohde; G Molinari; M Oggioni; G Pozzi; C A Guzman; G S Chhatwal
Journal:  Cell Microbiol       Date:  2000-12       Impact factor: 3.715

2.  SmaI macrorestriction analysis of Italian isolates of erythromycin-resistant Streptococcus pyogenes and correlations with macrolide-resistance phenotypes.

Authors:  S Ripa; C Zampaloni; L A Vitali; E Giovanetti; M P Montanari; M Prenna; P E Varaldo
Journal:  Microb Drug Resist       Date:  2001       Impact factor: 3.431

3.  Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci.

Authors:  B Beall; R Facklam; T Thompson
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

Review 4.  Horizontal gene transfer among group A streptococci: implications for pathogenesis and epidemiology.

Authors:  M A Kehoe; V Kapur; A M Whatmore; J M Musser
Journal:  Trends Microbiol       Date:  1996-11       Impact factor: 17.079

5.  Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis.

Authors:  A Osterlund; R Popa; T Nikkilä; A Scheynius; L Engstrand
Journal:  Laryngoscope       Date:  1997-05       Impact factor: 3.325

6.  Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route.

Authors:  E Medina; S R Talay; G S Chhatwal; C A Guzmán
Journal:  Eur J Immunol       Date:  1998-03       Impact factor: 5.532

7.  The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of group A streptococci by epithelial cells.

Authors:  G Molinari; S R Talay; P Valentin-Weigand; M Rohde; G S Chhatwal
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

8.  A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.

Authors:  H Seppälä; M Skurnik; H Soini; M C Roberts; P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

9.  Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1.

Authors:  V Ozeri; I Rosenshine; D F Mosher; R Fässler; E Hanski
Journal:  Mol Microbiol       Date:  1998-11       Impact factor: 3.501

10.  Protein F1 is required for efficient entry of Streptococcus pyogenes into epithelial cells.

Authors:  J Jadoun; V Ozeri; E Burstein; E Skutelsky; E Hanski; S Sela
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

View more
  11 in total

1.  ICESp2905, the erm(TR)-tet(O) element of Streptococcus pyogenes, is formed by two independent integrative and conjugative elements.

Authors:  Eleonora Giovanetti; Andrea Brenciani; Erika Tiberi; Alessandro Bacciaglia; Pietro Emanuele Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2011-10-10       Impact factor: 5.191

2.  Survey of phenotypic and genetic features of streptococcus pyogenes strains isolated in Northwest Italy.

Authors:  Simona Bianco; Tiziano Allice; Mario Zucca; Dianella Savoia
Journal:  Curr Microbiol       Date:  2005-12-26       Impact factor: 2.188

3.  Association between resistance to erythromycin and the presence of the fibronectin binding protein F1 gene, prtF1, in Streptococcus pyogenes isolates from German pediatric patients.

Authors:  Maria Haller; Kirsten Fluegge; Sandra Jasminder Arri; Brit Adams; Reinhard Berner
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  Flexible architecture of the Streptococcus pyogenes FCT genome region: finally the clue for understanding purulent skin diseases and long-term persistence?

Authors:  Andreas Podbielski
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

5.  Clonal spread of macrolide- and tetracycline-resistant [erm(A) tet(O)] emm77 Streptococcus pyogenes isolates in Italy and Norway.

Authors:  Claudio Palmieri; Manuela Vecchi; Pia Littauer; Arnfinn Sundsfjord; Pietro E Varaldo; Bruna Facinelli
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

6.  Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation.

Authors:  Lucilla Baldassarri; Roberta Creti; Simona Recchia; Monica Imperi; Bruna Facinelli; Eleonora Giovanetti; Marco Pataracchia; Giovanna Alfarone; Graziella Orefici
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

7.  ICESp1116, the genetic element responsible for erm(B)-mediated, inducible resistance to erythromycin in Streptococcus pyogenes.

Authors:  Andrea Brenciani; Erika Tiberi; Eleonora Morici; Erman Oryasin; Eleonora Giovanetti; Pietro E Varaldo
Journal:  Antimicrob Agents Chemother       Date:  2012-10-01       Impact factor: 5.191

8.  DNA methylase activity as a marker for the presence of a family of phage-like elements conferring efflux-mediated macrolide resistance in streptococci.

Authors:  T A Figueiredo; S I Aguiar; J Melo-Cristino; M Ramirez
Journal:  Antimicrob Agents Chemother       Date:  2006-09-05       Impact factor: 5.191

9.  Antimicrobial activity of essential oils and carvacrol, and synergy of carvacrol and erythromycin, against clinical, erythromycin-resistant Group A Streptococci.

Authors:  Gloria Magi; Emanuela Marini; Bruna Facinelli
Journal:  Front Microbiol       Date:  2015-03-03       Impact factor: 5.640

10.  Transduction of the Streptococcus pyogenes bacteriophage Φm46.1, carrying resistance genes mef(A) and tet(O), to other Streptococcus species.

Authors:  Eleonora Giovanetti; Andrea Brenciani; Gianluca Morroni; Erika Tiberi; Sonia Pasquaroli; Marina Mingoia; Pietro E Varaldo
Journal:  Front Microbiol       Date:  2015-01-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.